--Grace Therapeutics, Inc., a late-stage, biopharma company advancing GTx-104, a clinical-stage, novel, injectable formulation of nimodipine being developed for IV infusion to address significant ...

Denver's Tats for Tails event on June 28 combines tattoos and charity, supporting shelter animals with a $200 donation for ink.